Major Study: Tylenol in Pregnancy Doesn't Cause Autism

A significant new analysis published in The Lancet conclusively demonstrates no causal relationship between prenatal exposure to Tylenol and neurodevelopmental disorders in children. Researchers examined over 40 global studies, finding the best available human evidence does not support links to autism, ADHD, or intellectual disabilities. This extensive review reinforces current medical advice from organizations like the American College of Obstetricians and Gynecologists, which endorse acetaminophen as the primary choice for pain and fever management during pregnancy.

The study's methodology was lauded for its strength, incorporating sibling comparisons to account for shared genetics and environment. This approach helps mitigate confounding factors that may have affected earlier, smaller-scale research. The findings directly challenge controversial statements made recently regarding Tylenol's potential impact on child development, which lacked strong scientific backing. Medical experts worldwide had previously refuted these claims, emphasizing the safety of acetaminophen over other pain relievers during gestation.

Experts stress that untreated maternal pain and high fever can present risks to both mother and fetus, while alternative medications like aspirin and ibuprofen carry known pregnancy-related hazards. Kenvue, the maker of Tylenol, affirmed that independent science supports acetaminophen's safety. The comprehensive analysis suggests that any previously suggested associations likely stem from other factors, such as maternal health conditions or genetic predispositions, rather than the medication itself.